Skip Navigation

ACS is committed to helping combat the global COVID-19 pandemic with initiatives and free resources. Learn More

Jeff Zablocki

Jeff Zablocki

Jeff Zablocki is a Senior Director at Gilead Sciences where he leads a team of scientists working on targets in multiple therapeutic areas such as cardiovascular, oncology, inflammation, and antiviral. He has served as the ACS MEDI Chair and is an ACS Fellow.